New metallocene-bridged cyclodextrin dimer: A stable derivative of the antitumor drug titanocene dichloride and its potent cytotoxity against human breast cancer (MCF-7) cells

Zhenda Lu, Changsheng Lu, Xiaoming Ren, Qingjin Meng

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

A novel cyclodextrin dimer bridged with titanocene moiety, titanocene di[mono[6-deoxy-6-(2-(thio-1,2-dicyane ethylenylthio)ethyl thio-1,2-dicyane ethylenylthio)]-β-cyclodextrin] (6), has been synthesized and characterized by IR spectroscopy, UV spectroscopy, thermogravimetry, MALDI-TOF MS spectrum, 1H and 13C NMR spectroscopy. Especially, its potent cytotoxity against Human Breast Cancer (MCF-7) has also been studied.

Original languageEnglish
Pages (from-to)5895-5899
Number of pages5
JournalJournal of Organometallic Chemistry
Volume691
Issue number26
DOIs
StatePublished - 15 Dec 2006
Externally publishedYes

Keywords

  • Cytotoxity
  • Titanocene complex
  • Titanocene di[mono[6-deoxy-6-(2-(thio-1,2-dicyane ethylenylthio)ethyl thio-1,2-dicyane ethylenylthio)]-β-cyclodextrin]
  • β-Cyclodextrin dimer

Fingerprint

Dive into the research topics of 'New metallocene-bridged cyclodextrin dimer: A stable derivative of the antitumor drug titanocene dichloride and its potent cytotoxity against human breast cancer (MCF-7) cells'. Together they form a unique fingerprint.

Cite this